Practice question

Answer the question and get instant feedback.

MediumCardiologyHFrEF optimisationukmlamrcp part 1mrcgp akt

A 79-year-old man with known heart failure with reduced ejection fraction (HFrEF) is on ramipril, bisoprolol, and furosemide. He remains symptomatic (NYHA II-III) with NT-proBNP elevated and eGFR 68. Which additional disease-modifying therapy is recommended?

Practice more on iatroX

Educational content. Not a substitute for clinical judgement or local policy.